Predicting Pathologic Complete Response to Neoadjuvant Treatment in HER2-positive Breast Cancer using Interpretable Classification

Breast cancer is a significant global health problem, and HER2-positive breast cancer accounts for a substantial proportion of cases. The combination of Trastuzumab and Pertuzumab monoclonal antibodies with chemotherapy has demonstrated effectiveness in achieving pathologic complete response (pCR) a...

Full description

Saved in:
Bibliographic Details
Main Authors: Sergio Peñafiel, Esteban Ramírez, Nelson Baloian, Isabel Saffie, Paulo Luz, Inti Paredes
Format: Article
Language:English
Published: Graz University of Technology 2025-08-01
Series:Journal of Universal Computer Science
Subjects:
Online Access:https://lib.jucs.org/article/164692/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!